American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed, Text Revision. Washington DC: American Psychiatric Association; 2013.
Mehler PS, Birmingham LC, Crow SJ, Jahraus JP. Medical Complications of Eating Disorders. Grilo CM, Mitchell JE. The Treatment of Eating Disorders: A Clinical Handbook. New York: The Guilford Press; 2010. 66.
Brown CA, Mehler PS. Medical complications of self-induced vomiting. Eat Disord. 2013. 21 (4):287-94. [QxMD MEDLINE Link].
Brown CA, Mehler PS. Successful "detoxing" from commonly utilized modes of purging in bulimia nervosa. Eat Disord. 2012. 20 (4):312-20. [QxMD MEDLINE Link].
Denholm M, Jankowski J. Gastroesophageal reflux disease and bulimia nervosa: a review of the literature. Dis Esophagus. 2011 Feb. 24 (2):79-85. [QxMD MEDLINE Link].
Treasure J, Claudino AM, Zucker N. Eating disorders. Lancet. 2010 Feb 13. 375(9714):583-93. [QxMD MEDLINE Link].
Academy for Eating Disorders' (AED) Medical Care Standards Committee. Eating Disorders: A Guide to Medical Care — Academy for Eating Disorders Report 2021. 4th ed. [Full Text].
Crone C, Fochtmann LJ, Attia E, Boland R, Escobar J, Fornari V, et al. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders. Am J Psychiatry. 2023 Feb 1. 180 (2):167-171. [QxMD MEDLINE Link].
Hudson, JI, Hirpi, E, Pope, HG, et al. The prevalence and correlates of eating disorders in National Comorbidity Survey Replication. Biol Psychiatry. 2—7;61:348-358.
Ghaderi A, Odeberg J, Gustafsson S, Råstam M, Brolund A, Pettersson A, et al. Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and meta-analysis. Peer Journal. 2018 Jun. 21;6:e5113. doi: 10.7717/peerj.5113. eCollection 2018. [QxMD MEDLINE Link].
Goldfield GS, Blouin AG, Woodside DB. Body image, binge eating, and bulimia nervosa in male bodybuilders. Can J Psychiatry. 2006 Mar. 51(3):160-8. [QxMD MEDLINE Link].
Arthur-Cameselle JN, Burgos J, Burke J, Cairo J, Colón M, Piña ME. Factors that assist and hinder efforts towards recovery from eating disorders: a comparison of collegiate female athletes and non-athletes. Eat Disord. 2018 Nov-Dec. 26(6):538-55. [QxMD MEDLINE Link].
Ravaldi C, Vannacci A, Bolognesi E, Mancini S, Faravelli C, Ricca V. Gender role, eating disorder symptoms, and body image concern in ballet dancers. J Psychosom Res. 2006 Oct. 61(4):529-35. [QxMD MEDLINE Link].
Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011 Jul. 68(7):724-31. [QxMD MEDLINE Link].
Cassidy O, Sbrocco T, Tanofsky-Kraff M. Utilizing non-traditional research designs to explore culture-specific risk factors for eating disorders in African American adolescents. Adv Eat Disord. 2015 Jan. 3(1):91-102. [QxMD MEDLINE Link].
Franko DL, Becker AE, Thomas JJ, Herzog DB. Cross-ethnic differences in eating disorder symptoms and related distress. Int J Eat Disord. 2007 Mar. 40(2):156-64. [QxMD MEDLINE Link]. [Full Text].
Morgan CD, Marsh C. Bulimia nervosa in an elderly male: a case report. Int J Eat Disord. 2006 Mar. 39(2):170-1. [QxMD MEDLINE Link]. [Full Text].
Ágh T, Kovács G, Supina D, Pawaskar M, Herman BK, Vokó Z, et al. A systematic review of the health-related quality of life and economic burdens of anorexia nervosa, bulimia nervosa, and binge eating disorder. Eat Weight Disord. 2016 Sep. 21(3):353-64. [QxMD MEDLINE Link].
Fichter MM, Quadflieg N. Long-term stability of eating disorder diagnoses. Int J Eat Disord. 2007 Nov. 40 Suppl:S61-6. [QxMD MEDLINE Link]. [Full Text].
Fichter, MM, Quadflieg, N, Hedlund, S. Long term course of binge eating disorder and bulimia nervosa: relevance for nosology and diagnostic criteria. Int J Eat Disorders. 2008. 41:577-586.
Arikian, A, Keel, PK, Miler, KG. Parental psychopathology as a predictor of long-term outcome in bulimia nervosa patients. Eating Disorders. 2008. 16:30-39.
Grilo CM, Pagano ME, Skodol AE, et al. Natural course of bulimia nervosa and of eating disorder not otherwise specified: 5-year prospective study of remissions, relapses, and the effects of personality disorder psychopathology. J Clin Psychiatry. 2007 May. 68(5):738-46. [QxMD MEDLINE Link]. [Full Text].
Björck C, Clinton D, Sohlberg S, Norring C. Negative self-image and outcome in eating disorders: results at 3-year follow-up. Eat Behav. 2007 Aug. 8(3):398-406. [QxMD MEDLINE Link].
Fosse GK, Holen A. Childhood maltreatment in adult female psychiatric outpatients with eating disorders. Eat Behav. 2006 Nov. 7(4):404-9. [QxMD MEDLINE Link].
Micali N, Holliday J, Karwautz A, et al. Childhood eating and weight in eating disorders: a multi-centre European study of affected women and their unaffected sisters. Psychother Psychosom. 2007. 76(4):234-41. [QxMD MEDLINE Link].
Fernandez-Aranda F, Krug I, Granero R, et al. Individual and family eating patterns during childhood and early adolescence: an analysis of associated eating disorder factors. Appetite. 2007 Sep. 49(2):476-85. [QxMD MEDLINE Link].
Mikami AY, Hinshaw SP, Patterson KA, Lee JC. Eating pathology among adolescent girls with attention-deficit/hyperactivity disorder. J Abnorm Psychol. 2008 Feb. 117(1):225-35. [QxMD MEDLINE Link].
Eddy KT, Dorer DJ, Franko DL, Tahilani K, Thompson-Brenner H, Herzog DB. Should bulimia nervosa be subtyped by history of anorexia nervosa? A longitudinal validation. Int J Eat Disord. 2007 Nov. 40 Suppl:S67-71. [QxMD MEDLINE Link]. [Full Text].
Svaldi J, Schmitz F, Baur J, Hartmann AS, Legenbauer T, Thaler C, et al. Experiences of shame and guilt in anorexia and bulimia nervosa: a systematic review. Psychol Psychother. 2018 Sep 4. doi: 10.1111/papt.12198. [Epub ahead of print]:[QxMD MEDLINE Link].
Ruiz MC, Soler-Gonzalez J. Images in clinical medicine. Unfortunate ingestion. N Engl J Med. 2005 Nov 24. 353(21):2270. [QxMD MEDLINE Link]. [Full Text].
Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999 Dec 4. 319(7223):1467-8. [QxMD MEDLINE Link]. [Full Text].
Cotton MA, Ball C, Robinson P. Four simple questions can help screen for eating disorders. J Gen Intern Med. 2003 Jan. 18(1):53-6. [QxMD MEDLINE Link]. [Full Text].
Mintz LB, O'Halloran MS. The Eating Attitudes Test: validation with DSM-IV eating disorder criteria. J Pers Assess. 2000 Jun. 74(3):489-503. [QxMD MEDLINE Link].
Keery H, Boutelle K, van den Berg P, Thompson JK. The impact of appearance-related teasing by family members. J Adolesc Health. 2005 Aug. 37(2):120-7. [QxMD MEDLINE Link].
Poyastro Pinheiro A, Thornton LM, Plotonicov KH, et al. Patterns of menstrual disturbance in eating disorders. Int J Eat Disord. 2007 Jul. 40(5):424-34. [QxMD MEDLINE Link]. [Full Text].
Pinheiro, AP, Thornton, LH, Plotonicov, KH, et al. Patterns of menstrual disturbance in eating disorders. Intl J Eat Disord. 2007. 40:424-434.
Ribases M, Fernandez-Aranda F, Gratacos M, et al. Contribution of the serotoninergic system to anxious and depressive traits that may be partially responsible for the phenotypical variability of bulimia nervosa. J Psychiatr Res. 2008 Jan. 42(1):50-7. [QxMD MEDLINE Link].
Monteleone P, Santonastaso P, Mauri M, et al. Investigation of the serotonin transporter regulatory region polymorphism in bulimia nervosa: relationships to harm avoidance, nutritional parameters, and psychiatric comorbidity. Psychosom Med. 2006 Jan-Feb. 68(1):99-103. [QxMD MEDLINE Link]. [Full Text].
Fetissov SO, Harro J, Jaanisk M, et al. Autoantibodies against neuropeptides are associated with psychological traits in eating disorders. Proc Natl Acad Sci U S A. 2005 Oct 11. 102(41):14865-70. [QxMD MEDLINE Link]. [Full Text].
Bacanu SA, Bulik CM, Klump KL, et al. Linkage analysis of anorexia and bulimia nervosa cohorts using selected behavioral phenotypes as quantitative traits or covariates. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 5. 139B(1):61-8. [QxMD MEDLINE Link]. [Full Text].
Mercader JM, Ribases M, Gratacos M, et al. Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav. 2007 Nov. 6(8):706-16. [QxMD MEDLINE Link]. [Full Text].
Ando T, Komaki G, Naruo T, et al. Possible role of preproghrelin gene polymorphisms in susceptibility to bulimia nervosa. Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5. 141B(8):929-34. [QxMD MEDLINE Link]. [Full Text].
Uher R, Treasure J. Brain lesions and eating disorders. J Neurol Neurosurg Psychiatry. 2005 Jun. 76(6):852-7. [QxMD MEDLINE Link]. [Full Text].
Frank GK, Bailer UF, Meltzer CC, et al. Regional cerebral blood flow after recovery from anorexia or bulimia nervosa. Int J Eat Disord. 2007 Sep. 40(6):488-92. [QxMD MEDLINE Link]. [Full Text].
Godart NT, Perdereau F, Rein Z, et al. Comorbidity studies of eating disorders and mood disorders. Critical review of the literature. J Affect Disord. 2007 Jan. 97(1-3):37-49. [QxMD MEDLINE Link].
Mazzeo SE, Slof-Op't Landt MC, Jones I, et al. Associations among postpartum depression, eating disorders, and perfectionism in a population-based sample of adult women. Int J Eat Disord. 2006 Apr. 39(3):202-11. [QxMD MEDLINE Link]. [Full Text].
Micali N, Hilton K, Natatani E, et al. Is childhood OCD a risk factor for eating disorders later in life? A longitudinal study. Psychol Med. 2011 Jun 7. 1-7. [QxMD MEDLINE Link].
Duncan AE, Neuman RJ, Kramer JR, Kuperman S, Hesselbrock VM, Bucholz KK. Lifetime psychiatric comorbidity of alcohol dependence and bulimia nervosa in women. Drug Alcohol Depend. 2006 Sep 1. 84(1):122-32. [QxMD MEDLINE Link].
Solmi M, Veronese N, Sergi G, Luchini C, Favaro A, Santonastaso P, et al. The association between smoking prevalence and eating disorders: a systematic review and meta-analysis. Addiction. 2016 Nov. 111(11):1914-22. [QxMD MEDLINE Link].
Baker JH, Mazzeo SE, Kendler KS. Association between broadly defined bulimia nervosa and drug use disorders: common genetic and environmental influences. Int J Eat Disord. 2007 Dec. 40(8):673-8. [QxMD MEDLINE Link]. [Full Text].
Striegel-Moore RH, Franko DL, Thompson D, Barton B, Schreiber GB, Daniels SR. Caffeine intake in eating disorders. Int J Eat Disord. 2006 Mar. 39(2):162-5. [QxMD MEDLINE Link]. [Full Text].
Fernandez-Aranda F, Jimenez-Murcia S, Alvarez-Moya EM, Granero R, Vallejo J, Bulik CM. Impulse control disorders in eating disorders: clinical and therapeutic implications. Compr Psychiatry. 2006 Nov-Dec. 47(6):482-8. [QxMD MEDLINE Link].
Surman CB, Randall ET, Biederman J. Association between attention-deficit/hyperactivity disorder and bulimia nervosa: analysis of 4 case-control studies. J Clin Psychiatry. 2006 Mar. 67(3):351-4. [QxMD MEDLINE Link]. [Full Text].
Yates, WR, Lund, BC, Johnson, C, et al. Attention deficit hyperactivity symptoms and disorder in eating disorder inpatients. Int J Eat Disord. 2009. 42:375-378.
Wonderlich SA, Rosenfeldt S, Crosby RD, et al. The effects of childhood trauma on daily mood lability and comorbid psychopathology in bulimia nervosa. J Trauma Stress. 2007 Feb. 20(1):77-87. [QxMD MEDLINE Link]. [Full Text].
Zeeck A, Birindelli E, Sandholz A, Joos A, Herzog T, Hartmann A. Symptom severity and treatment course of bulimic patients with and without a borderline personality disorder. Eur Eat Disord Rev. 2007 Nov. 15(6):430-8. [QxMD MEDLINE Link]. [Full Text].
Waller G, Sines J, Meyer C, Foster E, Skelton A. Narcissism and narcissistic defences in the eating disorders. Int J Eat Disord. 2007 Mar. 40(2):143-8. [QxMD MEDLINE Link]. [Full Text].
Stein KF, Corte C. Identity impairment and the eating disorders: content and organization of the self-concept in women with anorexia nervosa and bulimia nervosa. Eur Eat Disord Rev. 2007 Jan. 15(1):58-69. [QxMD MEDLINE Link]. [Full Text].
Pisetsky EM, Wonderlich SA, Crosby RD, Peterson CB, Mitchell JE, Engel SG, et al. Depression and personality traits associated with emotion dysregulation: correlates of suicide attempts in women with bulimia nervosa. Eur Eat Disord Rev. 2015 Nov. 23(6):537-44. [QxMD MEDLINE Link].
Crow, SJ, Peterson CB, Swanson, SA. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry. 2009. 166:1343-1346.
Mandel L, Abai S. Diagnosing bulimia nervosa with parotid gland swelling. J Am Dent Assoc. 2004 May. 135(5):613-6; quiz 655. [QxMD MEDLINE Link]. [Full Text].
Kisely S, Baghaie H, Lalloo R, Johnson NW. Association between poor oral health and eating disorders: systematic review and meta-analysis. Br J Psychiatry. 2015 Oct. 207(4):299-305. [QxMD MEDLINE Link].
Glorio R, Allevato M, De Pablo A, et al. Prevalence of cutaneous manifestations in 200 patients with eating disorders. Int J Dermatol. 2000 May. 39(5):348-53. [QxMD MEDLINE Link]. [Full Text].
Strumia R. Dermatologic signs in patients with eating disorders. Am J Clin Dermatol. 2005. 6(3):165-73. [QxMD MEDLINE Link].
de Jonge P, Alonso J, Stein DJ, Kiejna A, Aguilar-Gaxiola S, Viana MC, et al. Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression. Diabetologia. 2014 Apr. 57(4):699-709. [QxMD MEDLINE Link].
Scherag,S, Hebebrand, J, Hinney, A. Eating disorders: the current status of molecular genetic research. Eur Child Adolesc Psychiatry. 2010. 19:211-226.
Kaye,W. Neurobiology of anorexia and bulimia nervosa. Physiology & Behavior 94. (2008). 121-135.
Bailer, UF, Kaye, WH. A review of neuropeptides and neuroendocrine dysregulation in anorexia nervosa and bulimia nervosa. CNS and Neurological Disorders. 2003. 2:53-59.
Monteleone P, Maj M. Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. Psychoneuroendocrinology. 2013 Mar. 38 (3):312-30. [QxMD MEDLINE Link].
Sadock BJ, and Sadock VA. Eating Disorders. Grebb, J.A., Pataki, C.S., and Sussman, N. Synopsis of Psychiatry. 10th Edition. Lippincott, Williams, & Wilkins; 2007. Chapter 23.
Brauser D. Excessive Exercise Predicts Suicidal Behavior in Eating Disorders. Medscape Medical News. Apr 18 2013. Available at https://www.medscape.com/viewarticle/782742. Accessed: Apr 22 2013.
Smith AR, Fink EL, Anestis MD, Ribeiro JD, Gordon KH, Davis H, et al. Exercise caution: Over-exercise is associated with suicidality among individuals with disordered eating. Psychiatry Res. 2013 Apr 30. 206(2-3):246-55. [QxMD MEDLINE Link].
Kruger D. Bulimia nervosa: easy to hide but essential to recognize. JAAPA. 2008 Jan. 21(1):48-52. [QxMD MEDLINE Link].
Donnelly B, Touyz S, Hay P, Burton A, Russell J, Caterson I. Neuroimaging in bulimia nervosa and binge eating disorder: a systematic review. J Eat Disord. 2018 Feb. 20(6)3:1-24. [QxMD MEDLINE Link]. [Full Text].
Bosanac P, Kurlender S, Stojanovska L, et al. Neuropsychological study of underweight and "weight-recovered" anorexia nervosa compared with bulimia nervosa and normal controls. Int J Eat Disord. 2007 Nov. 40(7):613-21. [QxMD MEDLINE Link]. [Full Text].
Brand M, Franke-Sievert C, Jacoby GE, Markowitsch HJ, Tuschen-Caffier B. Neuropsychological correlates of decision making in patients with bulimia nervosa. Neuropsychology. 2007 Nov. 21(6):742-50. [QxMD MEDLINE Link].
Griffiths S, Rossell SL, Mitchison D, Murray SB, Mond JM. Pathways into treatment for eating disorders: a quantitative examination of treatment barriers and treatment attitudes. Eat Disord. 2018 Nov-Dec. 26(6):556-74. [QxMD MEDLINE Link].
Ali K, Farrer L, Fassnacht DB, Gulliver A, Bauer S, Griffiths KM. Perceived barriers and facilitators towards help-seeking for eating disorders: a systematic review. Int J Eat Disord. 2017 Jan. 50(1):9-21. [QxMD MEDLINE Link].
Stockford C, Stenfert Kroese B, Beesley A, Leung N. Women's recovery from anorexia nervosa: a systematic review and meta-synthesis of qualitative research. Eat Disord. 2018 Sep. 24:1-26. [QxMD MEDLINE Link].
Shapiro JR, Berkman ND, Brownley KA, Sedway JA, Lohr KN, Bulik CM. Bulimia nervosa treatment: a systematic review of randomized controlled trials. Int J Eat Disord. 2007 May. 40(4):321-36. [QxMD MEDLINE Link]. [Full Text].
Mitchell JE, Agras WS, Wilson GT, Halmi K, Kraemer H, Crow S. A trial of a relapse prevention strategy in women with bulimia nervosa who respond to cognitive-behavior therapy. Int J Eat Disord. 2004 May. 35(4):549-55. [QxMD MEDLINE Link].
Slade E, Keeney E, Mavranezouli I, Dias S, Fou L, Stockton S, et al. Treatments for bulimia nervosa: a network meta-analysis. Psychol Med. 2018 Dec. 48(16):2629-2636. [QxMD MEDLINE Link].
Cooper Z, Fairburn CG. The evolution of "enhanced" cognitive behavior therapy for eating disorders: learning from treatment nonresponse. Cogn Behav Pract. 2011 Aug. 18 (3):394-402. [QxMD MEDLINE Link].
Bulik CM, Marcus MD, Zerwas S, Levine MD, La Via M. The changing "weightscape" of bulimia nervosa. Am J Psychiatry. 2012 Oct. 169 (10):1031-6. [QxMD MEDLINE Link].
de Jong M, Schoorl M, Hoek HW. Enhanced cognitive behavioural therapy for patients with eating disorders: a systematic review. Curr Opin Psychiatry. 2018 Nov. 31(6):436-444. [QxMD MEDLINE Link].
Miniati M, Callari A, Maglio A, Calugi S. Interpersonal psychotherapy for eating disorders: current perspectives. Psychol Res Behav Manag. 2018 Sep 5. 11:353-369. [QxMD MEDLINE Link].
Le Grange D, Lock J, Agras WS, Bryson SW, Jo B. Randomized clinical trial of family-based treatment and cognitive-behavioral therapy for adolescent bulimia nervosa. J Am Acad Child Adolesc Psychiatry. 2015 Nov. 54 (11):886-94.e2. [QxMD MEDLINE Link].
Schembri C, Evans L. Adverse relationship processes: the attempts of women with bulimia nervosa symptoms to fit the perceived ideal of intimate partners. Eur Eat Disord Rev. 2008 Jan. 16(1):59-66. [QxMD MEDLINE Link]. [Full Text].
Mitchell JE, Agras S, Wonderlich S. Treatment of bulimia nervosa: where are we and where are we going?. Int J Eat Disord. 2007 Mar. 40(2):95-101. [QxMD MEDLINE Link]. [Full Text].
de Carvalho MR, Dias TRS, Duchesne M, Nardi AE, Appolinario JC. Virtual reality as a promising strategy in the assessment and treatment of bulimia nervosa and binge eating disorder: a systematic review. Behav Sci (Basel). 2017 Jul 9. 7(3):[QxMD MEDLINE Link]. [Full Text].
Self-help and guided self-help for eating disorders, Volume 4 [database online]. The Cochrane Database of Systematic Reviews: The Cochrane Library, The Cochrane Collaboration; 2002. Updated 2007.
Treatment of patients with eating disorders,third edition. American Psychiatric Association. Am J Psychiatry. 2006 Jul. 163(7 Suppl):4-54. [QxMD MEDLINE Link]. [Full Text].
Mitchell JE, Crow S. Medical complications of anorexia nervosa and bulimia nervosa. Curr Opin Psychiatry. 2006 Jul. 19(4):438-43. [QxMD MEDLINE Link].
Schlegl S, Bürger C, Schmidt L, Herbst N, Voderholzer U. The potential of technology-based psychological interventions for anorexia and bulimia nervosa: a systematic review and recommendations for future research. J Med Internet Res. 2015 Mar 31. 17 (3):e85. [QxMD MEDLINE Link].
ter Huurne ED, de Haan HA, Postel MG, van der Palen J, VanDerNagel JE, DeJong CA. Web-based cognitive behavioral therapy for female patients with eating disorders: randomized controlled trial. J Med Internet Res. 2015 Jun 18. 17 (6):e152. [QxMD MEDLINE Link].
Mayer LE, Walsh BT. The use of selective serotonin reuptake inhibitors in eating disorders. J Clin Psychiatry. 1998. 59 Suppl 15:28-34. [QxMD MEDLINE Link].
Milano W, Siano C, Putrella C, Capasso A. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Ther. 2005 May-Jun. 22(3):278-83. [QxMD MEDLINE Link].
Leombruni P, Amianto F, Delsedime N, Gramaglia C, Abbate-Daga G, Fassino S. Citalopram versus fluoxetine for the treatment of patients with bulimia nervosa: a single-blind randomized controlled trial. Adv Ther. 2006 May-Jun. 23(3):481-94. [QxMD MEDLINE Link].
Walsh BT, Sysko R, Parides MK. Early response to desipramine among women with bulimia nervosa. Int J Eat Disord. 2006 Jan. 39(1):72-5. [QxMD MEDLINE Link]. [Full Text].
Bacaltchuk J, Hay P. Antidepressants versus placebo for people with bulimia nervosa. Cochrane Database Syst Rev. 2003. CD003391. [QxMD MEDLINE Link].
McElroy SL, Arnold LM, Shapira NA, et al. Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial. Am J Psychiatry. 2003 Feb. 160(2):255-61. [QxMD MEDLINE Link].
Arbaizar, B, Gomez-Acebo, I, Llorca, J. Efficacy of Topiramate in bulimia nervosa an binge-eating disorder: a systematic review. General Hospital Psychiatry. 2008. 30:471-475.
Hsu LK, Clement L, Santhouse R, Ju ES. Treatment of bulimia nervosa with lithium carbonate. A controlled study. J Nerv Ment Dis. 1991 Jun. 179(6):351-5. [QxMD MEDLINE Link].
Faris PL, Kim SW, Meller WH, et al. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet. 2000 Mar 4. 355(9206):792-7. [QxMD MEDLINE Link].
Broft AI, Spanos A, Corwin RL, et al. Baclofen for binge eating: an open-label trial. Int J Eat Disord. 2007 Dec. 40(8):687-91. [QxMD MEDLINE Link]. [Full Text].
Naessen S, Carlstrom K, Bystrom B, Pierre Y, Hirschberg AL. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women. Psychoneuroendocrinology. 2007 Jun. 32(5):548-54. [QxMD MEDLINE Link].
Broft A, Berner LA, Walsh BT. Pharmacotherapy for Bulimia Nervosa. Grilo CM, Mitchell JE. The Treatment of Eating Disorders: A Clinical Handbook. New York: The Guilford Press; 2010. 388.
Psychotherapy for bulimia nervosa and binging, Volume 1 [database online]. The Cochrane Database of Systematic Reviews: The Cochrane Library, The Cochrane Collaboration; 1998. Updated 2005.
Antidepressants versus psychological treatments and their combination for bulimia nervosa [database online]. The Cochrane Database of Systematic Reviews: The Cochrane Library, The Cochrane Collaboration; 1997. Updated 2005.
Jacobi C, Morris L, Beckers C, et al. Maintenance of internet-based prevention: a randomized controlled trial. Int J Eat Disord. 2007 Mar. 40(2):114-9. [QxMD MEDLINE Link].
Ljotsson B, Lundin C, Mitsell K, Carlbring P, Ramklint M, Ghaderi A. Remote treatment of bulimia nervosa and binge eating disorder: a randomized trial of Internet-assisted cognitive behavioural therapy. Behav Res Ther. 2007 Apr. 45(4):649-61. [QxMD MEDLINE Link]. [Full Text].
Robinson S, Perkins S, Bauer S, Hammond N, Treasure J, Schmidt U. Aftercare intervention through text messaging in the treatment of bulimia nervosa--feasibility pilot. Int J Eat Disord. 2006 Dec. 39(8):633-8. [QxMD MEDLINE Link]. [Full Text].
Adson DE, Mitchell JE, Trenkner SW. The superior mesenteric artery syndrome and acute gastric dilatation in eating disorders: a report of two cases and a review of the literature. Int J Eat Disord. 1997 Mar. 21(2):103-14. [QxMD MEDLINE Link].
DeBate RD, Shuman D, Tedesco LA. Eating disorders in the oral health curriculum. J Dent Educ. 2007 May. 71(5):655-63. [QxMD MEDLINE Link]. [Full Text].
Haines, J, Neumark=Sztainer, D, Perry, CL, et al. V.I.K. (Very Important Kids): a school based program designed to reduce teasing and unhealthy weight-control behaviors. Health Education Research-Theory and Practic. 2006. 21(6):884-895.
Crone C, Fochtmann LJ, Attia E, Boland R, Escobar J, Fornari V, et al. The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders. Am J Psychiatry. 2023 Feb 1. 180 (2):167-171. [QxMD MEDLINE Link].
Burton KW. APA Releases Updated Eating Disorder Guidelines. Medscape Medical News. Available at https://www.medscape.com/viewarticle/989058. March 3, 2023; Accessed: March 31, 2023.
Couturier J, Isserlin L, Norris M, et al. Canadian practice guidelines for the treatment of children and adolescents with eating disorders. J Eat Disord. 2020. 8:4. [QxMD MEDLINE Link].
Brauser D. Autoimmune diseases implicated in eating disorders. Medscape Medical News. September 8, 2014. [Full Text].
Raevuori A, Haukka J, Vaarala O, Suvisaari JM, Gissler M, Grainger M, et al. The increased risk for autoimmune diseases in patients with eating disorders. PLoS One. 2014. 9(8):e104845. [QxMD MEDLINE Link]. [Full Text].
Woodside BD, Staab R. Management of psychiatric comorbidity in anorexia nervosa and bulimia nervosa. CNS Drugs. 2006. 20(8):655-63. [QxMD MEDLINE Link].
Goebel-Fabbri, AE, Fikkan, J, Franko, DL, et al. Insulin restriction and associated morbidity and mortality in women with type 1 diabetes. Diabetes Care. 2008. 31:415-419.
Micali N, Treasure J, Simonoff E. Eating disorders symptoms in pregnancy: a longitudinal study of women with recent and past eating disorders and obesity. J Psychosom Res. 2007 Sep. 63(3):297-303. [QxMD MEDLINE Link].
Micali N, Simonoff E, Treasure J. Risk of major adverse perinatal outcomes in women with eating disorders. Br J Psychiatry. 2007 Mar. 190:255-9. [QxMD MEDLINE Link]. [Full Text].
Marsden P, Karagianni E, Morgan JF. Spirituality and clinical care in eating disorders: a qualitative study. Int J Eat Disord. 2007 Jan. 40(1):7-12. [QxMD MEDLINE Link]. [Full Text].
Graap H, Bleich S, Herbst F, Trostmann Y, Wancata J, de Zwaan M. The needs of carers of patients with anorexia and bulimia nervosa. Eur Eat Disord Rev. 2008 Jan. 16(1):21-9. [QxMD MEDLINE Link]. [Full Text].
Brooks M. Enhanced CBT Bests Psychoanalysis for Bulimia. Medscape Medical News. Available at https://www.medscape.com/viewarticle/815300. Accessed: December 8, 2013.
Button E, Aldridge S. Season of birth and eating disorders: patterns across diagnoses in a specialized eating disorders service. Int J Eat Disord. 2007 Jul. 40(5):468-71. [QxMD MEDLINE Link].
Lehoux PM, Howe N. Perceived non-shared environment, personality traits, family factors and developmental experiences in bulimia nervosa. Br J Clin Psychol. 2007 Mar. 46:47-66. [QxMD MEDLINE Link].
Morgan JF, Lacey JH. Season of birth and bulimia nervosa. Int J Eat Disord. 2000 May. 27(4):452-8. [QxMD MEDLINE Link]. [Full Text].
Poulsen S, Lunn S, Daniel SI, Folke S, Mathiesen BB, Katznelson H, et al. A randomized controlled trial of psychoanalytic psychotherapy or cognitive-behavioral therapy for bulimia nervosa. Am J Psychiatry. 2013 Nov 26. [QxMD MEDLINE Link].
Wolcott, RB, Yager, J, Gordon, G. Dental sequelae to the binge-purge syndrome (bulimia): report of cases. JADA. 1984. 109:723-725.
Monteleone AM, Pellegrino F, Croatto G, et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neurosci Biobehav Rev. 2022 Nov. 142:104857. [QxMD MEDLINE Link].
Monteleone AM, Pellegrino F, Croatto G, et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neurosci Biobehav Rev. 2022 Nov. 142:104857. [QxMD MEDLINE Link].
Monteleone AM, Pellegrino F, Croatto G, et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neurosci Biobehav Rev. 2022 Nov. 142:104857. [QxMD MEDLINE Link].
Monteleone AM, Pellegrino F, Croatto G, et al. Treatment of eating disorders: A systematic meta-review of meta-analyses and network meta-analyses. Neurosci Biobehav Rev. 2022 Nov. 142:104857. [QxMD MEDLINE Link].
Tozzi F, Thornton LM, Klump KL, Fichter MM, Halmi KA, Kaplan AS, et al. Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Am J Psychiatry. 2005 Apr. 162 (4):732-40. [QxMD MEDLINE Link].
Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007 Feb 1. 61 (3):348-58. [QxMD MEDLINE Link].
Silén Y, Keski-Rahkonen A. Worldwide prevalence of DSM-5 eating disorders among young people. Curr Opin Psychiatry. 2022 Nov 1. 35 (6):362-371. [QxMD MEDLINE Link].
Chua SN, Fitzsimmons-Craft EE, Austin SB, Wilfley DE, Taylor CB. Estimated prevalence of eating disorders in Malaysia based on a diagnostic screen. Int J Eat Disord. 2022 Jun. 55 (6):763-775. [QxMD MEDLINE Link].
Koposov RA, Stickley A, Ruchkin V. Bulimia Symptoms in Russian Youth: Prevalence and Association With Internalizing Problems. Front Psychiatry. 2021. 12:797388. [QxMD MEDLINE Link].
Crow SJ, Peterson CB, Swanson SA, Raymond NC, Specker S, Eckert ED, et al. Increased mortality in bulimia nervosa and other eating disorders. Am J Psychiatry. 2009 Dec. 166 (12):1342-6. [QxMD MEDLINE Link].
van Hoeken D, Hoek HW. Review of the burden of eating disorders: mortality, disability, costs, quality of life, and family burden. Curr Opin Psychiatry. 2020 Nov. 33 (6):521-527. [QxMD MEDLINE Link].
Tith RM, Paradis G, Potter BJ, Low N, Healy-Profitós J, He S, et al. Association of Bulimia Nervosa With Long-term Risk of Cardiovascular Disease and Mortality Among Women. JAMA Psychiatry. 2020 Jan 1. 77 (1):44-51. [QxMD MEDLINE Link].
Carrino EA, Flatt RE, Pawar PS, Sanzari CM, Tregarthen JP, Argue S, et al. Sociodemographic and clinical characteristics of treated and untreated adults with bulimia nervosa or binge-eating disorder recruited for a large-scale research study. J Eat Disord. 2023 Jul 31. 11 (1):126. [QxMD MEDLINE Link].
Traut P, Halbeisen G, Braks K, Huber TJ, Paslakis G. Sociodemographic and clinical features of men and women with eating disorders: a diagnosis-matched, retrospective comparison among inpatients. Front Psychiatry. 2023. 14:1192693. [QxMD MEDLINE Link].
Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022 Jan. 27 (1):281-295. [QxMD MEDLINE Link].
Avena NM, Bocarsly ME, Hoebel BG. Animal models of sugar and fat bingeing: relationship to food addiction and increased body weight. Methods Mol Biol. 2012. 829:351-65. [QxMD MEDLINE Link].
Avena NM, Bocarsly ME, Rada P, Kim A, Hoebel BG. After daily bingeing on a sucrose solution, food deprivation induces anxiety and accumbens dopamine/acetylcholine imbalance. Physiol Behav. 2008 Jun 9. 94 (3):309-15. [QxMD MEDLINE Link].
Johnson PM, Kenny PJ. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci. 2010 May. 13 (5):635-41. [QxMD MEDLINE Link].
Cai X, Liu H, Feng B, Yu M, He Y, Liu H, et al. A D2 to D1 shift in dopaminergic inputs to midbrain 5-HT neurons causes anorexia in mice. Nat Neurosci. 2022 May. 25 (5):646-658. [QxMD MEDLINE Link].
Monteleone P, Maj M. Dysfunctions of leptin, ghrelin, BDNF and endocannabinoids in eating disorders: beyond the homeostatic control of food intake. Psychoneuroendocrinology. 2013 Mar. 38 (3):312-30. [QxMD MEDLINE Link].
Berner LA, Brown TA, Lavender JM, Lopez E, Wierenga CE, Kaye WH. Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin. Mol Cell Endocrinol. 2019 Nov 1. 497:110320. [QxMD MEDLINE Link].
Monteleone AM, Castellini G, Volpe U, Ricca V, Lelli L, Monteleone P, et al. Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3. 80 (Pt B):132-142. [QxMD MEDLINE Link].
Broft A, Shingleton R, Kaufman J, Liu F, Kumar D, Slifstein M, et al. Striatal dopamine in bulimia nervosa: a PET imaging study. Int J Eat Disord. 2012 Jul. 45 (5):648-56. [QxMD MEDLINE Link].
Mihov Y, Treyer V, Akkus F, Toman E, Milos G, Ametamey SM, et al. Metabotropic glutamate receptor 5 in bulimia nervosa. Sci Rep. 2020 Apr 14. 10 (1):6374. [QxMD MEDLINE Link].
Mitchell JS, Anijärv TE, Levenstein JL, Hermens DF, Lagopoulos J. Excitatory and inhibitory neurometabolites in anorexia nervosa: A systematic review of proton magnetic resonance spectroscopy studies. Neurosci Biobehav Rev. 2023 Sep. 152:105279. [QxMD MEDLINE Link].
Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci. 2002 May 1. 22 (9):3306-11. [QxMD MEDLINE Link].
Plassmann H, O'Doherty JP, Rangel A. Appetitive and aversive goal values are encoded in the medial orbitofrontal cortex at the time of decision making. J Neurosci. 2010 Aug 11. 30 (32):10799-808. [QxMD MEDLINE Link].
Puglisi-Allegra S, Ventura R. Prefrontal/accumbal catecholamine system processes emotionally driven attribution of motivational salience. Rev Neurosci. 2012. 23 (5-6):509-26. [QxMD MEDLINE Link].
Kelley AE, Baldo BA, Pratt WE, Will MJ. Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav. 2005 Dec 15. 86 (5):773-95. [QxMD MEDLINE Link].
O'Doherty JP, Dayan P, Friston K, Critchley H, Dolan RJ. Temporal difference models and reward-related learning in the human brain. Neuron. 2003 Apr 24. 38 (2):329-37. [QxMD MEDLINE Link].
Frank GKW, Shott ME, Stoddard J, Swindle S, Pryor TL. Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders. JAMA Psychiatry. 2021 Oct 1. 78 (10):1123-1133. [QxMD MEDLINE Link].
Mueller SV, Morishima Y, Schwab S, Wiest R, Federspiel A, Hasler G. Neural Correlates of Impaired Reward-Effort Integration in Remitted Bulimia Nervosa. Neuropsychopharmacology. 2018 Mar. 43 (4):868-876. [QxMD MEDLINE Link].
Bohon C, Stice E. Negative affect and neural response to palatable food intake in bulimia nervosa. Appetite. 2012 Jun. 58 (3):964-70. [QxMD MEDLINE Link].
Cyr M, Wang Z, Tau GZ, Zhao G, Friedl E, Stefan M, et al. Reward-Based Spatial Learning in Teens With Bulimia Nervosa. J Am Acad Child Adolesc Psychiatry. 2016 Nov. 55 (11):962-971.e3. [QxMD MEDLINE Link].
Frank GK. Altered brain reward circuits in eating disorders: chicken or egg?. Curr Psychiatry Rep. 2013 Oct. 15 (10):396. [QxMD MEDLINE Link].
Lee JE, Namkoong K, Jung YC. Impaired prefrontal cognitive control over interference by food images in binge-eating disorder and bulimia nervosa. Neurosci Lett. 2017 Jun 9. 651:95-101. [QxMD MEDLINE Link].
Dreyfuss MFW, Riegel ML, Pedersen GA, Cohen AO, Silverman MR, Dyke JP, et al. Patients with bulimia nervosa do not show typical neurodevelopment of cognitive control under emotional influences. Psychiatry Res Neuroimaging. 2017 Aug 30. 266:59-65. [QxMD MEDLINE Link].
Jacobs MJ, Roesch S, Wonderlich SA, Crosby R, Thornton L, Wilfley DE, et al. Anorexia nervosa trios: behavioral profiles of individuals with anorexia nervosa and their parents. Psychol Med. 2009 Mar. 39 (3):451-61. [QxMD MEDLINE Link].
Lilenfeld LR. Personality and temperament. Curr Top Behav Neurosci. 2011. 6:3-16. [QxMD MEDLINE Link].
Kaye W. Neurobiology of anorexia and bulimia nervosa. Physiol Behav. 2008 Apr 22. 94 (1):121-35. [QxMD MEDLINE Link].
Boureau YL, Dayan P. Opponency revisited: competition and cooperation between dopamine and serotonin. Neuropsychopharmacology. 2011 Jan. 36 (1):74-97. [QxMD MEDLINE Link].
Frank GKW. From Desire to Dread-A Neurocircuitry Based Model for Food Avoidance in Anorexia Nervosa. J Clin Med. 2021 May 21. 10 (11):[QxMD MEDLINE Link].
Castro DC, Cole SL, Berridge KC. Lateral hypothalamus, nucleus accumbens, and ventral pallidum roles in eating and hunger: interactions between homeostatic and reward circuitry. Front Syst Neurosci. 2015. 9:90. [QxMD MEDLINE Link].
Li BU, Lefevre F, Chelimsky GG, Boles RG, Nelson SP, Lewis DW, et al. North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition consensus statement on the diagnosis and management of cyclic vomiting syndrome. J Pediatr Gastroenterol Nutr. 2008 Sep. 47 (3):379-93. [QxMD MEDLINE Link].
Bahji A, Brothers TD, Danilewitz M. Considering Cannabis Use in Differential Diagnosis: A Teachable Moment. JAMA Intern Med. 2022 Jan 1. 182 (1):66-67. [QxMD MEDLINE Link].
Eddy KT, Tabri N, Thomas JJ, Murray HB, Keshaviah A, Hastings E, et al. Recovery From Anorexia Nervosa and Bulimia Nervosa at 22-Year Follow-Up. J Clin Psychiatry. 2017 Feb. 78 (2):184-189. [QxMD MEDLINE Link].
Blundell JE, Gillett A. Control of food intake in the obese. Obes Res. 2001 Nov. 9 Suppl 4:263S-270S. [QxMD MEDLINE Link].
Craighead LW, Agras WS. Mechanisms of action in cognitive-behavioral and pharmacological interventions for obesity and bulimia nervosa. J Consult Clin Psychol. 1991 Feb. 59 (1):115-25. [QxMD MEDLINE Link].
de Zwaan M. Binge eating disorder and obesity. Int J Obes Relat Metab Disord. 2001 May. 25 Suppl 1:S51-5. [QxMD MEDLINE Link].
Devlin MJ. Binge-eating disorder and obesity. A combined treatment approach. Psychiatr Clin North Am. 2001 Jun. 24 (2):325-35. [QxMD MEDLINE Link].
de Zwaan M, Mitchell JE, Raymond NC, Spitzer RL. Binge eating disorder: clinical features and treatment of a new diagnosis. Harv Rev Psychiatry. 1994 Mar-Apr. 1 (6):310-25. [QxMD MEDLINE Link].
Thompson RA. Emotion regulation: a theme in search of definition. Monogr Soc Res Child Dev. 1994. 59 (2-3):25-52. [QxMD MEDLINE Link].
Berking, M. Affect Regulation Training: A Practitioners' Manual. New York, NY: Springer Science+Business Media, LLC; 2014.
Lavender JM, Wonderlich SA, Engel SG, Gordon KH, Kaye WH, Mitchell JE. Dimensions of emotion dysregulation in anorexia nervosa and bulimia nervosa: A conceptual review of the empirical literature. Clin Psychol Rev. 2015 Aug. 40:111-22. [QxMD MEDLINE Link].
Engel SG, Crosby RD, Thomas G, Bond D, Lavender JM, Mason T, et al. Ecological Momentary Assessment in Eating Disorder and Obesity Research: a Review of the Recent Literature. Curr Psychiatry Rep. 2016 Apr. 18 (4):37. [QxMD MEDLINE Link].
Berg KC, Crosby RD, Cao L, Crow SJ, Engel SG, Wonderlich SA, et al. Negative affect prior to and following overeating-only, loss of control eating-only, and binge eating episodes in obese adults. Int J Eat Disord. 2015 Sep. 48 (6):641-53. [QxMD MEDLINE Link].
Haedt-Matt AA, Keel PK. Revisiting the affect regulation model of binge eating: a meta-analysis of studies using ecological momentary assessment. Psychol Bull. 2011 Jul. 137 (4):660-681. [QxMD MEDLINE Link].
Bickel WK, Jarmolowicz DP, Mueller ET, Gatchalian KM, McClure SM. Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology (Berl). 2012 Jun. 221 (3):361-87. [QxMD MEDLINE Link].
Gerlach G, Herpertz S, Loeber S. Personality traits and obesity: a systematic review. Obes Rev. 2015 Jan. 16 (1):32-63. [QxMD MEDLINE Link].
Waxman SE. A systematic review of impulsivity in eating disorders. Eur Eat Disord Rev. 2009 Nov. 17 (6):408-25. [QxMD MEDLINE Link].
Lavender JM, Green D, Anestis MD, Tull MT, Gratz KL. Negative affect, negative urgency, thought suppression, and bulimic symptoms: a moderated mediation analysis in a sample at-risk for bulimic symptoms. Eur Eat Disord Rev. 2015 May. 23 (3):246-50. [QxMD MEDLINE Link].
Wenzel KR, Weinstock J, Vander Wal JS, Weaver TL. Examining the role of negative urgency in a predictive model of bulimic symptoms. Eat Behav. 2014 Aug. 15 (3):343-9. [QxMD MEDLINE Link].
Racine SE, Burt SA, Keel PK, Sisk CL, Neale MC, Boker S, et al. Examining associations between negative urgency and key components of objective binge episodes. Int J Eat Disord. 2015 Jul. 48 (5):527-31. [QxMD MEDLINE Link].
Pearson CM, Wonderlich SA, Smith GT. A risk and maintenance model for bulimia nervosa: From impulsive action to compulsive behavior. Psychol Rev. 2015 Jul. 122 (3):516-35. [QxMD MEDLINE Link].
Culbert KM, Lavender JM, Crosby RD, Wonderlich SA, Engel SG, Peterson CB, et al. Associations between negative affect and binge/purge behaviors in women with anorexia nervosa: Considering the role of negative urgency. Compr Psychiatry. 2016 Apr. 66:104-12. [QxMD MEDLINE Link].
Lavender JM, Utzinger LM, Cao L, Wonderlich SA, Engel SG, Mitchell JE, et al. Reciprocal associations between negative affect, binge eating, and purging in the natural environment in women with bulimia nervosa. J Abnorm Psychol. 2016 Apr. 125 (3):381-6. [QxMD MEDLINE Link].
Racine SE, Martin SJ. Exploring divergent trajectories: Disorder-specific moderators of the association between negative urgency and dysregulated eating. Appetite. 2016 Aug 1. 103:45-53. [QxMD MEDLINE Link].
De Young KP, Zander M, Anderson DA. Beliefs about the emotional consequences of eating and binge eating frequency. Eat Behav. 2014 Jan. 15 (1):31-6. [QxMD MEDLINE Link].
Fischer S, Smith GT, Anderson KG. Clarifying the role of impulsivity in bulimia nervosa. Int J Eat Disord. 2003 May. 33 (4):406-11. [QxMD MEDLINE Link].
Bijttebier P, Beck I, Claes L, Vandereycken W. Gray's Reinforcement Sensitivity Theory as a framework for research on personality-psychopathology associations. Clin Psychol Rev. 2009 Jul. 29 (5):421-30. [QxMD MEDLINE Link].
Gray JA. The psychophysiological basis of introversion-extraversion. Behav Res Ther. 1970 Aug. 8 (3):249-66. [QxMD MEDLINE Link].
Wu M, Brockmeyer T, Hartmann M, Skunde M, Herzog W, Friederich HC. Reward-related decision making in eating and weight disorders: A systematic review and meta-analysis of the evidence from neuropsychological studies. Neurosci Biobehav Rev. 2016 Feb. 61:177-96. [QxMD MEDLINE Link].
Kessler RM, Hutson PH, Herman BK, Potenza MN. The neurobiological basis of binge-eating disorder. Neurosci Biobehav Rev. 2016 Apr. 63:223-38. [QxMD MEDLINE Link].
Wierenga CE, Ely A, Bischoff-Grethe A, Bailer UF, Simmons AN, Kaye WH. Are Extremes of Consumption in Eating Disorders Related to an Altered Balance between Reward and Inhibition?. Front Behav Neurosci. 2014. 8:410. [QxMD MEDLINE Link].
Frank GKW, Reynolds JR, Shott ME, O'Reilly RC. Altered temporal difference learning in bulimia nervosa. Biol Psychiatry. 2011 Oct 15. 70 (8):728-735. [QxMD MEDLINE Link].
Voon V, Morris LS, Irvine MA, Ruck C, Worbe Y, Derbyshire K, et al. Risk-taking in disorders of natural and drug rewards: neural correlates and effects of probability, valence, and magnitude. Neuropsychopharmacology. 2015 Mar. 40 (4):804-12. [QxMD MEDLINE Link].
Cyders MA, Smith GT. Emotion-based dispositions to rash action: positive and negative urgency. Psychol Bull. 2008 Nov. 134 (6):807-28. [QxMD MEDLINE Link].
Okon-Singer H, Hendler T, Pessoa L, Shackman AJ. The neurobiology of emotion-cognition interactions: fundamental questions and strategies for future research. Front Hum Neurosci. 2015. 9:58. [QxMD MEDLINE Link].
Gilmartin MR, Balderston NL, Helmstetter FJ. Prefrontal cortical regulation of fear learning. Trends Neurosci. 2014 Aug. 37 (8):455-64. [QxMD MEDLINE Link].
Rolls ET. A biased activation theory of the cognitive and attentional modulation of emotion. Front Hum Neurosci. 2013. 7:74. [QxMD MEDLINE Link].
Yokum S, Stice E. Cognitive regulation of food craving: effects of three cognitive reappraisal strategies on neural response to palatable foods. Int J Obes (Lond). 2013 Dec. 37 (12):1565-70. [QxMD MEDLINE Link].
Stice E, Yokum S, Burger KS, Epstein LH, Small DM. Youth at risk for obesity show greater activation of striatal and somatosensory regions to food. J Neurosci. 2011 Mar 23. 31 (12):4360-6. [QxMD MEDLINE Link].
Joos AA, Saum B, Zeeck A, Perlov E, Glauche V, Hartmann A, et al. Frontocingular dysfunction in bulimia nervosa when confronted with disease-specific stimuli. Eur Eat Disord Rev. 2011 Sep-Oct. 19 (5):447-53. [QxMD MEDLINE Link].
Balodis IM, Molina ND, Kober H, Worhunsky PD, White MA, Rajita Sinha, et al. Divergent neural substrates of inhibitory control in binge eating disorder relative to other manifestations of obesity. Obesity (Silver Spring). 2013 Feb. 21 (2):367-77. [QxMD MEDLINE Link].
Marsh R, Steinglass JE, Gerber AJ, Graziano O'Leary K, Wang Z, Murphy D, et al. Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa. Arch Gen Psychiatry. 2009 Jan. 66 (1):51-63. [QxMD MEDLINE Link].
Marsh R, Horga G, Wang Z, Wang P, Klahr KW, Berner LA, et al. An FMRI study of self-regulatory control and conflict resolution in adolescents with bulimia nervosa. Am J Psychiatry. 2011 Nov. 168 (11):1210-20. [QxMD MEDLINE Link].
Haukoos JS, Lewis RJ. The Propensity Score. JAMA. 2015 Oct 20. 314 (15):1637-8. [QxMD MEDLINE Link].
Bohon C, Stice E. Negative affect and neural response to palatable food intake in bulimia nervosa. Appetite. 2012 Jun. 58 (3):964-70. [QxMD MEDLINE Link].
Corwin RL, Avena NM, Boggiano MM. Feeding and reward: perspectives from three rat models of binge eating. Physiol Behav. 2011 Jul 25. 104 (1):87-97. [QxMD MEDLINE Link].
Logue SF, Gould TJ. The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition. Pharmacol Biochem Behav. 2014 Aug. 123:45-54. [QxMD MEDLINE Link].
Fineberg NA, Potenza MN, Chamberlain SR, Berlin HA, Menzies L, Bechara A, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010 Feb. 35 (3):591-604. [QxMD MEDLINE Link].
London ED. Impulsivity, Stimulant Abuse, and Dopamine Receptor Signaling. Adv Pharmacol. 2016. 76:67-84. [QxMD MEDLINE Link].
Bailer UF, Bloss CS, Frank GK, Price JC, Meltzer CC, Mathis CA, et al. 5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups. Int J Eat Disord. 2011 Sep. 44 (6):477-87. [QxMD MEDLINE Link].
Bailer UF, Frank GK, Price JC, Meltzer CC, Becker C, Mathis CA, et al. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res. 2013 Feb 28. 211 (2):160-8. [QxMD MEDLINE Link].
Murray S, Tulloch A, Gold MS, Avena NM. Hormonal and neural mechanisms of food reward, eating behaviour and obesity. Nat Rev Endocrinol. 2014 Sep. 10 (9):540-52. [QxMD MEDLINE Link].
Scott MM, Xu Y, Elias CF, Williams KW. Central regulation of food intake, body weight, energy expenditure, and glucose homeostasis. Front Neurosci. 2014. 8:384. [QxMD MEDLINE Link].
Culbert KM, Racine SE, Klump KL. Hormonal Factors and Disturbances in Eating Disorders. Curr Psychiatry Rep. 2016 Jul. 18 (7):65. [QxMD MEDLINE Link].
Sam AH, Troke RC, Tan TM, Bewick GA. The role of the gut/brain axis in modulating food intake. Neuropharmacology. 2012 Jul. 63 (1):46-56. [QxMD MEDLINE Link].
Maniam J, Morris MJ. The link between stress and feeding behaviour. Neuropharmacology. 2012 Jul. 63 (1):97-110. [QxMD MEDLINE Link].
Barbano MF, Cador M. Opioids for hedonic experience and dopamine to get ready for it. Psychopharmacology (Berl). 2007 Apr. 191 (3):497-506. [QxMD MEDLINE Link].
Kelley AE, Bakshi VP, Fleming S, Holahan MR. A pharmacological analysis of the substrates underlying conditioned feeding induced by repeated opioid stimulation of the nucleus accumbens. Neuropsychopharmacology. 2000 Oct. 23 (4):455-67. [QxMD MEDLINE Link].
Avena NM, Bocarsly ME. Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa. Neuropharmacology. 2012 Jul. 63 (1):87-96. [QxMD MEDLINE Link].
Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997 Mar 14. 275 (5306):1593-9. [QxMD MEDLINE Link].
Frank GK. Recent advances in neuroimaging to model eating disorder neurobiology. Curr Psychiatry Rep. 2015 Apr. 17 (4):559. [QxMD MEDLINE Link].
Frank GK. What causes eating disorders, and what do they cause?. Biol Psychiatry. 2015 Apr 1. 77 (7):602-3. [QxMD MEDLINE Link].
O'Hara CB, Campbell IC, Schmidt U. A reward-centred model of anorexia nervosa: a focussed narrative review of the neurological and psychophysiological literature. Neurosci Biobehav Rev. 2015 May. 52:131-52. [QxMD MEDLINE Link].
Frank GK. Advances in the diagnosis of anorexia nervosa and bulimia nervosa using brain imaging. Expert Opin Med Diagn. 2012 May 1. 6 (3):235-244. [QxMD MEDLINE Link].
O'Doherty JP, Dayan P, Friston K, Critchley H, Dolan RJ. Temporal difference models and reward-related learning in the human brain. Neuron. 2003 Apr 24. 38 (2):329-37. [QxMD MEDLINE Link].
Agras, W. S., Dorian, B., Kirkley, B. G., et al. Imipramine in the treatment of bulimia: A double-blind controlled study. Int J Eat Disord. 1987. 6(1):29–38.
Pope HG Jr, Hudson JI, Jonas JM, Yurgelun-Todd D. Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry. 1983 May. 140 (5):554-8. [QxMD MEDLINE Link].
Mitchell JE, Groat R. A placebo-controlled, double-blind trial of amitriptyline in bulimia. J Clin Psychopharmacol. 1984 Aug. 4 (4):186-93. [QxMD MEDLINE Link].
Mitchell JE, Pyle RL, Eckert ED, Hatsukami D, Pomeroy C, Zimmerman R. A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa. Arch Gen Psychiatry. 1990 Feb. 47 (2):149-57. [QxMD MEDLINE Link].
Agras WS, Rossiter EM, Arnow B, Schneider JA, Telch CF, Raeburn SD, et al. Pharmacologic and cognitive-behavioral treatment for bulimia nervosa: a controlled comparison. Am J Psychiatry. 1992 Jan. 149 (1):82-7. [QxMD MEDLINE Link].
Barlow J, Blouin J, Blouin A, Perez E. Treatment of bulimia with desipramine: a double-blind crossover study. Can J Psychiatry. 1988 Mar. 33 (2):129-33. [QxMD MEDLINE Link].
Blouin AG, Blouin JH, Perez EL, Bushnik T, Zuro C, Mulder E. Treatment of bulimia with fenfluramine and desipramine. J Clin Psychopharmacol. 1988 Aug. 8 (4):261-9. [QxMD MEDLINE Link].
McCann UD, Agras WS. Successful treatment of nonpurging bulimia nervosa with desipramine: a double-blind, placebo-controlled study. Am J Psychiatry. 1990 Nov. 147 (11):1509-13. [QxMD MEDLINE Link].
Walsh BT, Hadigan CM, Devlin MJ, Gladis M, Roose SP. Long-term outcome of antidepressant treatment for bulimia nervosa. Am J Psychiatry. 1991 Sep. 148 (9):1206-12. [QxMD MEDLINE Link].
Sabine EJ, Yonace A, Farrington AJ, Barratt KH, Wakeling A. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin. Br J Clin Pharmacol. 1983. 15 Suppl 2 (Suppl 2):195S-202S. [QxMD MEDLINE Link].
Carruba MO, Cuzzolaro M, Riva L, Bosello O, Liberti S, Castra R, et al. Efficacy and tolerability of moclobemide in bulimia nervosa: a placebo-controlled trial. Int Clin Psychopharmacol. 2001 Jan. 16 (1):27-32. [QxMD MEDLINE Link].
Walsh BT, Gladis M, Roose SP, Stewart JW, Stetner F, Glassman AH. Phenelzine vs placebo in 50 patients with bulimia. Arch Gen Psychiatry. 1988 May. 45 (5):471-5. [QxMD MEDLINE Link].
Walsh BT, Stewart JW, Roose SP, Gladis M, Glassman AH. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study. Arch Gen Psychiatry. 1984 Nov. 41 (11):1105-9. [QxMD MEDLINE Link].
Kennedy SH, Piran N, Warsh JJ, Prendergast P, Mainprize E, Whynot C, et al. A trial of isocarboxazid in the treatment of bulimia nervosa. J Clin Psychopharmacol. 1988 Dec. 8 (6):391-6. [QxMD MEDLINE Link].
Kennedy SH, Goldbloom DS, Ralevski E, Davis C, D'Souza JD, Lofchy J. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. J Clin Psychopharmacol. 1993 Dec. 13 (6):415-22. [QxMD MEDLINE Link].
Rothschild R, Quitkin HM, Quitkin FM, Stewart JW, Ocepek-Welikson K, McGrath PJ, et al. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives. Int J Eat Disord. 1994 Jan. 15 (1):1-9. [QxMD MEDLINE Link].
Horne RL, Ferguson JM, Pope HG Jr, Hudson JI, Lineberry CG, Ascher J, et al. Treatment of bulimia with bupropion: a multicenter controlled trial. J Clin Psychiatry. 1988 Jul. 49 (7):262-6. [QxMD MEDLINE Link].
Pope HG Jr, Keck PE Jr, McElroy SL, Hudson JI. A placebo-controlled study of trazodone in bulimia nervosa. J Clin Psychopharmacol. 1989 Aug. 9 (4):254-9. [QxMD MEDLINE Link].
Brambilla F, Draisci A, Peirone A, Brunetta M. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa. Neuropsychobiology. 1995. 32 (2):68-71. [QxMD MEDLINE Link].
Milano W, Siano C, Putrella C, Capasso A. Treatment of bulimia nervosa with fluvoxamine: a randomized controlled trial. Adv Ther. 2005 May-Jun. 22 (3):278-83. [QxMD MEDLINE Link].
Fichter MM, Krüger R, Rief W, Holland R, Döhne J. Fluvoxamine in prevention of relapse in bulimia nervosa: effects on eating-specific psychopathology. J Clin Psychopharmacol. 1996 Feb. 16 (1):9-18. [QxMD MEDLINE Link].
Fichter MM, Leibl C, Krüger R, Rief W. Effects of fluvoxamine on depression, anxiety, and other areas of general psychopathology in bulimia nervosa. Pharmacopsychiatry. 1997 May. 30 (3):85-92. [QxMD MEDLINE Link].
Schmidt U, Cooper PJ, Essers H, Freeman CP, Holland RL, Palmer RL, et al. Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy. J Clin Psychopharmacol. 2004 Oct. 24 (5):549-52. [QxMD MEDLINE Link].
Fluoxetine in the treatment of bulimia nervosa. A multicenter, placebo-controlled, double-blind trial. Fluoxetine Bulimia Nervosa Collaborative Study Group. Arch Gen Psychiatry. 1992 Feb. 49 (2):139-47. [QxMD MEDLINE Link].
Goldstein DJ, Wilson MG, Thompson VL, Potvin JH, Rampey AH Jr. Long-term fluoxetine treatment of bulimia nervosa. Fluoxetine Bulimia Nervosa Research Group. Br J Psychiatry. 1995 May. 166 (5):660-6. [QxMD MEDLINE Link].
Goldbloom DS, Olmsted M, Davis R, Clewes J, Heinmaa M, Rockert W, et al. A randomized controlled trial of fluoxetine and cognitive behavioral therapy for bulimia nervosa: short-term outcome. Behav Res Ther. 1997 Sep. 35 (9):803-11. [QxMD MEDLINE Link].
Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, et al. Medication and psychotherapy in the treatment of bulimia nervosa. Am J Psychiatry. 1997 Apr. 154 (4):523-31. [QxMD MEDLINE Link].
Romano SJ, Halmi KA, Sarkar NP, Koke SC, Lee JS. A placebo-controlled study of fluoxetine in continued treatment of bulimia nervosa after successful acute fluoxetine treatment. Am J Psychiatry. 2002 Jan. 159 (1):96-102. [QxMD MEDLINE Link].
Hsu LK, Clement L, Santhouse R, Ju ES. Treatment of bulimia nervosa with lithium carbonate. A controlled study. J Nerv Ment Dis. 1991 Jun. 179 (6):351-5. [QxMD MEDLINE Link].
Hoopes SP, Reimherr FW, Hedges DW, Rosenthal NR, Kamin M, Karim R, et al. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures. J Clin Psychiatry. 2003 Nov. 64 (11):1335-41. [QxMD MEDLINE Link].
Nickel C, Tritt K, Muehlbacher M, Pedrosa Gil F, Mitterlehner FO, Kaplan P, et al. Topiramate treatment in bulimia nervosa patients: a randomized, double-blind, placebo-controlled trial. Int J Eat Disord. 2005 Dec. 38 (4):295-300. [QxMD MEDLINE Link].
Faris PL, Kim SW, Meller WH, Goodale RL, Oakman SA, Hofbauer RD, et al. Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial. Lancet. 2000 Mar 4. 355 (9206):792-7. [QxMD MEDLINE Link].
Stice E, Marti CN, Spoor S, Presnell K, Shaw H. Dissonance and healthy weight eating disorder prevention programs: long-term effects from a randomized efficacy trial. J Consult Clin Psychol. 2008 Apr. 76 (2):329-40. [QxMD MEDLINE Link].
Franko DL, Tabri N, Keshaviah A, Murray HB, Herzog DB, Thomas JJ, et al. Predictors of long-term recovery in anorexia nervosa and bulimia nervosa: Data from a 22-year longitudinal study. J Psychiatr Res. 2018 Jan. 96:183-188. [QxMD MEDLINE Link].